[go: up one dir, main page]

WO2002060905A2 - Procede pour preparer des intermediaires d'inhibiteurs de la protease du vih - Google Patents

Procede pour preparer des intermediaires d'inhibiteurs de la protease du vih Download PDF

Info

Publication number
WO2002060905A2
WO2002060905A2 PCT/US2001/046116 US0146116W WO02060905A2 WO 2002060905 A2 WO2002060905 A2 WO 2002060905A2 US 0146116 W US0146116 W US 0146116W WO 02060905 A2 WO02060905 A2 WO 02060905A2
Authority
WO
WIPO (PCT)
Prior art keywords
furan
propynyloxy
group
6alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/046116
Other languages
English (en)
Inventor
Roman Davis
Thomas Clairborne Lovelace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of WO2002060905A2 publication Critical patent/WO2002060905A2/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne un procédé pour effectuer des réactions de cyclisation intramoléculaire à l'aide de la lumière, sans initiateurs de radicaux, pour produire des composés polycycliques utiles.
PCT/US2001/046116 2000-10-24 2001-10-22 Procede pour preparer des intermediaires d'inhibiteurs de la protease du vih Ceased WO2002060905A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24282200P 2000-10-24 2000-10-24

Publications (1)

Publication Number Publication Date
WO2002060905A2 true WO2002060905A2 (fr) 2002-08-08

Family

ID=22916319

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2001/051428 Ceased WO2002067239A2 (fr) 2000-10-24 2001-10-22 Methode de preparation d'intermediaires d'inhibiteurs de protease vih
PCT/US2001/046116 Ceased WO2002060905A2 (fr) 2000-10-24 2001-10-22 Procede pour preparer des intermediaires d'inhibiteurs de la protease du vih

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2001/051428 Ceased WO2002067239A2 (fr) 2000-10-24 2001-10-22 Methode de preparation d'intermediaires d'inhibiteurs de protease vih

Country Status (4)

Country Link
EP (1) EP1404680A2 (fr)
JP (1) JP2004519473A (fr)
AU (1) AU2002255473A1 (fr)
WO (2) WO2002067239A2 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002975A1 (fr) * 2002-06-27 2004-01-08 Smithkline Beecham Corporation PREPARATION DE STEREOISOMERES DE (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO[2,3-b]FURAN-3-OL
US8153829B2 (en) 2006-11-09 2012-04-10 Janssen Pharmaceutica N.V. Methods for the preparation of hexahydrofuro[2,3-B]furan-3-ol
CN102516259A (zh) * 2006-03-29 2012-06-27 吉里德科学公司 制备hiv蛋白酶抑制剂的方法
CN103864813A (zh) * 2012-12-18 2014-06-18 上海迪赛诺化学制药有限公司 一种合成六氢呋喃并[2,3-b]呋喃-3-醇及其对映体的方法
CN107607635A (zh) * 2017-08-15 2018-01-19 东北制药集团股份有限公司 一种采用顶空气相色谱检测左磷右胺盐中丙炔醇含量的方法
US11827627B2 (en) 2021-06-04 2023-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
US11834441B2 (en) 2019-12-06 2023-12-05 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002975A1 (fr) * 2002-06-27 2004-01-08 Smithkline Beecham Corporation PREPARATION DE STEREOISOMERES DE (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO[2,3-b]FURAN-3-OL
CN102516259A (zh) * 2006-03-29 2012-06-27 吉里德科学公司 制备hiv蛋白酶抑制剂的方法
CN102516259B (zh) * 2006-03-29 2014-12-10 吉里德科学公司 制备hiv蛋白酶抑制剂的方法
US8153829B2 (en) 2006-11-09 2012-04-10 Janssen Pharmaceutica N.V. Methods for the preparation of hexahydrofuro[2,3-B]furan-3-ol
CN103864813A (zh) * 2012-12-18 2014-06-18 上海迪赛诺化学制药有限公司 一种合成六氢呋喃并[2,3-b]呋喃-3-醇及其对映体的方法
CN107607635A (zh) * 2017-08-15 2018-01-19 东北制药集团股份有限公司 一种采用顶空气相色谱检测左磷右胺盐中丙炔醇含量的方法
CN107607635B (zh) * 2017-08-15 2020-07-31 东北制药集团股份有限公司 一种采用顶空气相色谱检测左磷右胺盐中丙炔醇含量的方法
US11834441B2 (en) 2019-12-06 2023-12-05 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
US11919887B2 (en) 2019-12-06 2024-03-05 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
US12247021B2 (en) 2019-12-06 2025-03-11 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
US11827627B2 (en) 2021-06-04 2023-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
US12258333B2 (en) 2021-06-04 2025-03-25 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels

Also Published As

Publication number Publication date
JP2004519473A (ja) 2004-07-02
WO2002067239A2 (fr) 2002-08-29
WO2002067239A3 (fr) 2004-01-08
EP1404680A2 (fr) 2004-04-07
AU2002255473A1 (en) 2002-09-04

Similar Documents

Publication Publication Date Title
Ihara et al. Asymmetric total synthesis of atisine via intramolecular double Michael reaction
Martin et al. Application of nitrile oxide cycloadditions to a convergent, asymmetric synthesis of (+)-phyllanthocin
Li et al. Phosphine-containing Lewis base catalyzed cyclization of benzofuranone type electron-deficient alkenes with allenoates: a facile synthesis of spirocyclic benzofuranones
Majumdar et al. Synthesis of five-and six-membered heterocyclic compounds by the application of the metathesis reactions
Wang et al. N-heterocyclic carbene-catalyzed formal [3+ 3] annulation of alkynyl acylazoliums for the synthesis of benzofuro [3, 2-b] pyridin-2-ones
CN109641917A (zh) 可用于合成软海绵素大环内酯类及其类似物的普林斯反应和中间体
WO2002060905A2 (fr) Procede pour preparer des intermediaires d'inhibiteurs de la protease du vih
Rudroff et al. Synthesis of tetrahydrofuran-based natural products and their carba analogs via stereoselective enzyme mediated Baeyer–Villiger oxidation
Finch et al. Synthesis of the spiroacetal core of the cephalosporolide family of natural products
KR900005624B1 (ko) 에피포도필로톡신과 그 관련화합물 제조용 중간화합물 및 그 제조방법
Palange et al. TiCl 4-n-Bu 3 N-mediated cascade annulation of ketones with α-ketoesters: a facile synthesis of highly substituted fused γ-alkylidene-butenolides
Wang et al. Cocatalyst-controlled divergent cascade cycloaddition reaction of arylalkynols and dioxopyrrolidienes: access to spiroketals and oxa-bridged eight-membered cyclic ethers
Yan et al. Synthesis of bicyclic ortho-aminocarbonitrile derivatives catalyzed by 1, 4-diazabicyclo [2.2. 2] octane
US20040204595A1 (en) Process for preparing protease inhibitor intermediates
Peng et al. Enantioselective total synthesis of (+)-isoaltholactone
US20040026230A1 (en) Process for preparing intermediates of hiv protease inhibitors
Maezaki et al. 1, 5-Benzodithiepan-3-one 1, 5-dioxide: A novel chiral auxiliary for asymmetric desymmetrization of meso-1, 2-diols
Tanaka et al. CsF-Promoted Desilylation and Ring-Contraction Reaction of Electron-Deficient 3-Silyl-2H-chromenes to 2-Benzylbenzofurans
Momose et al. Bicyclo [3.3. 1] nonanes as synthetic intermediates. Part21. 1 Enantiodivergent synthesis of thecis, cis 2, 6-disubstituted piperidin-3-ol chiralbuilding block for alkaloid synthesis
JP4516752B2 (ja) トランス−縮合３，３ａ，８，１２ｂ−テトラヒドロ−２Ｈ−ジベンゾ［３，４：６，７］シクロヘプタ［１，２−ｂ］フラン誘導体の製造法
Hu et al. A flexible approach to the synthesis of type II and III lepadin alkaloids
Ghosh et al. A stereoselective anti-aldol route to (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-ol: a key ligand for a new generation of HIV protease inhibitors
AU2002352205A1 (en) Preparation of cis-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
Honda et al. An enantiocontrolled synthesis of (–)-malyngolide
B Luesse et al. Synthesis of a functionalized oxabicyclo [2.2. 1]-heptene-based chemical library

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
XX Miscellaneous:

Free format text: THE RECEIVING OFFICE HAS INFORMED THE IB THAT THIS INTERNATIONAL APPLICATION HAS BEEN ERRONEOUSLY ASSIGNED AN INTERENATIONAL FILING DATE AND IS VACATED AND REPLACED BY INTERNATIONAL APPLICATION PCT/US2001/051428. THE NOTICE WAS RECEIVED BY THE INTERNATIONAL BUREAU IN TIME TO PREVENT THE INTERNATIONAL PUBLICATION, HOWEVER, DUE TO A CLERICAL ERROR, THE APPLICATION PCT/US2001/046116 WAS NEVERTHELESS PUBLISHED ON 20020808 (THIS APPLICATION WAS PUBLISHED ON 20020829).

NENP Non-entry into the national phase

Ref country code: JP